Breaking News Instant updates and real-time market news.

BNTX

BioNTech

$0.00 /

+ (+0.00%)

06:35
10/10/19
10/10
06:35
10/10/19
06:35

BioNTech 10M share IPO priced at $15.00

The deal priced at the low-end of the revised $15.00-$16.00 range. JPMorgan, BofA/Merrill, UBS and SVB Leerink acted as joint book running managers for the offering.

  • 10

    Oct

TODAY'S FREE FLY STORIES

Options
Yandex put volume heavy and directionally bearish » 10:55
02/25/20
02/25
10:55
02/25/20
10:55
YNDX

Yandex

$40.99 /

-1.01 (-2.40%)

Bearish flow noted in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
Precision BioSciences initiated with an Outperform at William Blair » 10:51
02/25/20
02/25
10:51
02/25/20
10:51
DTIL

Precision BioSciences

$8.00 /

-0.25 (-3.03%)

William Blair analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Disney adds Beyond Meat competitor Impossible Foods to parks, cruise menus » 10:49
02/25/20
02/25
10:49
02/25/20
10:49
BYND

Beyond Meat

$113.26 /

-0.71 (-0.62%)

, DIS

Disney

$131.25 /

-1.78 (-1.34%)

Impossible Foods earlier…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Options
MGM Resorts call volume above normal and directionally bullish » 10:45
02/25/20
02/25
10:45
02/25/20
10:45
MGM

MGM Resorts

$29.15 /

-0.53 (-1.79%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

General news
The U.S. consumer confidence index » 10:45
02/25/20
02/25
10:45
02/25/20
10:45

The U.S. consumer…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

General news
4-Week Bill Announcement to be released at 11:00  10:45
02/25/20
02/25
10:45
02/25/20
10:45
 
General news
4-Week Bill Announcement to be released at 11:00  10:45
02/25/20
02/25
10:45
02/25/20
10:45
 
General news
8-Week Bill Announcement to be released at 11:00  10:45
02/25/20
02/25
10:45
02/25/20
10:45
 
General news
8-Week Bill Announcement to be released at 11:00  10:45
02/25/20
02/25
10:45
02/25/20
10:45
 
General news
Treasury Action: yields have dropped as Wall Street's gains fade » 10:40
02/25/20
02/25
10:40
02/25/20
10:40

Treasury Action: yields…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
Haverty Furniture Companies trading resumes  10:38
02/25/20
02/25
10:38
02/25/20
10:38
 
Recommendations
Apple EPS estimates lowered on COVID-19 at Needham » 10:36
02/25/20
02/25
10:36
02/25/20
10:36
AAPL

Apple

$299.50 /

+1.34 (+0.45%)

In a research note before…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Options
Nike put volume heavy and directionally bearish » 10:35
02/25/20
02/25
10:35
02/25/20
10:35
NKE

Nike

$95.75 /

-0.15 (-0.16%)

Bearish flow noted in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Harbert says Enzo Biochem holders voted for two board nominees » 10:34
02/25/20
02/25
10:34
02/25/20
10:34
ENZ

Enzo Biochem

$2.31 /

+0.07 (+3.13%)

Harbert Discovery Fund,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
Hot Stocks
Haverty Furniture Companies trading halted, volatility trading pause  10:33
02/25/20
02/25
10:33
02/25/20
10:33
 
Hot Stocks
Eaton completes acquisition of Power Distribution » 10:33
02/25/20
02/25
10:33
02/25/20
10:33
ETN

Eaton

$101.75 /

+0.11 (+0.11%)

Eaton announced it has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

On The Fly
Jefferies says buy Regeneron following Novartis' new eye drug safety issue » 10:33
02/25/20
02/25
10:33
02/25/20
10:33
REGN

Regeneron

$450.19 /

+23.9 (+5.61%)

, NVS

Novartis

$89.85 /

-0.22 (-0.24%)

Guggenheim analyst Seamus…

Open Full Text

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

On The Fly
Fly Intel: What to watch in SmileDirectClub's earnings report » 10:30
02/25/20
02/25
10:30
02/25/20
10:30
SDC

SmileDirectClub

$11.47 /

-0.37 (-3.13%)

, WMT

Walmart

$116.95 /

+0.59 (+0.51%)

SmileDirectClub (SDC) is…

Open Full Text

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Bicycle Therapeutics price target raised to $30 from $20 at Piper Sandler » 10:29
02/25/20
02/25
10:29
02/25/20
10:29
BCYC

Bicycle Therapeutics

$15.94 /

+0.94 (+6.27%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Options
Bilibili call volume above normal and directionally bullish » 10:25
02/25/20
02/25
10:25
02/25/20
10:25
BILI

Bilibili

$27.38 /

+0.46 (+1.71%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
UBS alternative energy analyst to hold an analyst/industry conference call » 10:25
02/25/20
02/25
10:25
02/25/20
10:25

Alternative Energy &…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Earnings
Fly Intel: What to watch in Salesforce earnings report » 10:20
02/25/20
02/25
10:20
02/25/20
10:20
CRM

Salesforce

$187.79 /

+1.88 (+1.01%)

, MSFT

Microsoft

$173.27 /

+2.39 (+1.40%)

, AMZN

Amazon.com

$2,017.94 /

+8.2 (+0.41%)

, AAPL

Apple

$299.73 /

+1.57 (+0.53%)

Salesforce (CRM) is…

Salesforce (CRM) is scheduled to report results of its fourth fiscal quarter after the market close on Tuesday, February 25, with a conference call scheduled for 5:00 pm ET. What to watch for: 1. GUIDANCE: Along with its third quarter earnings report, Salesforce raised its fiscal year 2020 adjusted earnings per share view to $2.89-$2.90 from $2.82-$2.84. Consensus for earnings, which was $2.86 at the time, has increased to $2.90. The company also reaffirmed its 2020 revenue view of $16.99B-$17B. Consensus, which was $16.9B at the time, has risen slightly to $17B. In addition, the company provided fourth quarter adjusted EPS guidance of 54c-55c on a revenue of $4.74B-$4.75B. Consensus for earnings, which was at 62c at the time, has dropped to 55c, and estimates for revenue, which was at $4.72B, have increased to $4.75B. 2. PARTNERSHIPS: In November, Salesforce expanded its strategic partnership with Microsoft (MSFT), naming Microsoft Azure as its public cloud provider for Salesforce Marketing Cloud. Additionally in November, Amazon Web Services (AMZN) and the company announced an expansion of their partnership with Salesforce introducing Service Cloud Voice which integrates Amazon Connect. The company also announced in November the launch of two apps and the next-generation Salesforce Mobile SDK as part of its strategic partnership with Apple (AAPL). 3. COO APPOINTMENT: In December, the company appointed president and Chief Product Officer Bret Taylor as president and COO. In the role, Taylor leads Salesforce's global product vision, engineering, security, marketing and communications. 4. ANALYST VIEWS: On Friday, UBS analyst Jennifer Lowe raised her price target on Salesforce to $230 and kept her Buy rating, noting that outside of its expected Q4 results, the stock trades at a discount of over 40% relative to valuation levels implied by its SaaS peers. Lowe believes that the market is undervaluing the potential of its future M&A, which she expects to be a likely ongoing part of its growth strategy. Lowe adds that she also sees Salesforce free cash flow growth sustaining in the mid-20% over the next 5 years whether its growth is organic or inorganic. BMO Capital analyst Keith Bachman also raised his price target on Salesforce to $220 and kept his Outperform rating ahead of its Q4 results. The analyst says the company continues to generate durable growth from its core portfolio and also sees the stock price attractively valued relative to its "high-growth software" peers. Meanwhile, Stifel analyst Tom Roderick raised the firm's price target on Salesforce to $210 from $195 following checks that pointed to "a solid and steady fundamental environment and outlook" for Salesforce as well as the broader group. His checks are indicating that Salesforce has taken an even more aggressive strategy with its Enterprise License Agreements and he has heard that the strategy is resonating, with Salesforce said to have signed over 5 ELAs with Fortune 100 companies in Q4. He kept a Buy rating on the shares.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Dyadic International announces expanded coronavirus collaboration with IIBR » 10:19
02/25/20
02/25
10:19
02/25/20
10:19
DYAI

Dyadic International

$5.35 /

+0.03 (+0.56%)

Dyadic International…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Technical Analysis
NASDAQ market internals summary » 10:17
02/25/20
02/25
10:17
02/25/20
10:17
$NSD

NASDAQ Market Internals

$0.00 /

+ (+0.00%)

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Hot Stocks
Dominion Energy's first battery storage projects approved » 10:16
02/25/20
02/25
10:16
02/25/20
10:16
D

Dominion

$89.97 /

+0.17 (+0.19%)

Dominion Energy Virginia…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.